Literature DB >> 1579251

Dystrophinopathy in isolated cases of myopathy in females.

E P Hoffman1, K Arahata, C Minetti, E Bonilla, L P Rowland.   

Abstract

X-linked dystrophinopathy is the most common cause of isolated cases of myopathy in males. To investigate dystrophin abnormalities as a cause of myopathy in girls and women, we used dystrophin immunocytochemistry to study muscle biopsies from 505 girls and women with neuromuscular disease. Forty-six muscle biopsies showed a combination of fibers containing or lacking dystrophin; this mosaic immunostaining pattern denoted a carrier status. Twenty-one of 46 (45.6%) had a family history of Duchenne muscular dystrophy in males. Twenty-five of 46 (54.3%) were isolated cases, with no previous family history of neuromuscular disorder. The laboratory findings of the isolated cases were consistent with the familial cases; all showed myopathic histopathology and abnormal elevations of serum CK. The clinical presentations of the isolated cases varied but were consistent with the familial cases: 40% (10/25) of isolated cases showed proximal limb weakness before age 10, 24% (6/25) presented with myalgias or cramps, 24% (6/25) presented with incidental findings of grossly elevated CK levels, 8% (2/25) noted easy fatigue, and 4% (1/25) had slowly progressive proximal limb weakness beginning at age 45. From our data, the clinical criteria for consideration of an underlying dystrophinopathy in isolated female cases of myopathy are CK levels greater than 1,000 IU/l and myopathic histopathology. About 10% of the isolated cases of hyperCKemic myopathy (25/210) were proven by dystrophin analysis to have a dystrophinopathy as the cause of their disease (manifesting carriers of Duchenne dystrophy). However, we feel that this may be an underestimate. The correct diagnosis in these patients is imperative for appropriate genetic counseling to the patients and their families.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1579251     DOI: 10.1212/wnl.42.5.967

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  23 in total

Review 1.  Restoring dystrophin expression in duchenne muscular dystrophy muscle progress in exon skipping and stop codon read through.

Authors:  Eric P Hoffman; Abby Bronson; Arthur A Levin; Shin'ichi Takeda; Toshifumi Yokota; Andreas R Baudy; Edward M Connor
Journal:  Am J Pathol       Date:  2011-05-23       Impact factor: 4.307

Review 2.  Clinical genetics in neurological disease.

Authors:  J C MacMillan; P S Harper
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-01       Impact factor: 10.154

3.  Genetic correction of dystrophin deficiency and skeletal muscle remodeling in adult MDX mouse via transplantation of retroviral producer cells.

Authors:  A Fassati; D J Wells; P A Sgro Serpente; F S Walsh; S C Brown; P N Strong; G Dickson
Journal:  J Clin Invest       Date:  1997-08-01       Impact factor: 14.808

4.  Uniform low-level dystrophin expression in the heart partially preserved cardiac function in an aged mouse model of Duchenne cardiomyopathy.

Authors:  Nalinda B Wasala; Yongping Yue; Jenna Vance; Dongsheng Duan
Journal:  J Mol Cell Cardiol       Date:  2016-11-29       Impact factor: 5.000

5.  Clinical and Genetic Characterization of Female Dystrophinopathy.

Authors:  Seung Ha Lee; Jung Hwan Lee; Kyung A Lee; Young Chul Choi
Journal:  J Clin Neurol       Date:  2015-05-28       Impact factor: 3.077

6.  Detection of new paternal dystrophin gene mutations in isolated cases of dystrophinopathy in females.

Authors:  E Pegoraro; R N Schimke; K Arahata; Y Hayashi; H Stern; H Marks; M R Glasberg; J E Carroll; J W Taber; H B Wessel
Journal:  Am J Hum Genet       Date:  1994-06       Impact factor: 11.025

7.  Abnormal dystrophin expression in patients with limb girdle syndromes.

Authors:  S Beyenburg; S Zierz; K Arahata; R R Mundegar; W Friedl; F Jerusalem
Journal:  J Neurol       Date:  1994-02       Impact factor: 4.849

8.  A histochemical and electron microscopic study of skeletal and cardiac muscle from a Fabry disease patient and carrier.

Authors:  M Uchino; E Uyama; H Kawano; J Hokamaki; K Kugiyama; Y Murakami; H Yasue; M Ando
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

Review 9.  Dilated cardiomyopathy and the dystrophin gene: an illustrated review.

Authors:  A Oldfors; B O Eriksson; M Kyllerman; T Martinsson; J Wahlström
Journal:  Br Heart J       Date:  1994-10

10.  Somatic mosaicism for Duchenne dystrophy: evidence for genetic normalization mitigating muscle symptoms.

Authors:  Akanchha Kesari; Robert Neel; Lynne Wagoner; Brennan Harmon; Christopher Spurney; Eric P Hoffman
Journal:  Am J Med Genet A       Date:  2009-07       Impact factor: 2.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.